Intravenous Immunoglobulin Therapy-Induced Erythema Multiforme in a Patient with Chronic Lymphocytic Leukemia [PDF]
Case Reports in Dermatology, 2023 This case report discusses immunoglobulin-induced erythema multiforme (EM), a rare and understudied condition that requires further investigation. The report presents the case of a 69-year-old woman with a history of chronic lymphocytic leukemia who ...
Angelina Konovalova +7 more
doaj +2 more sources
Intravenous immunoglobulin therapy in erythromelalgia management: a case report [PDF]
Einstein (São Paulo)A 49-year-old woman presented with a 16-year history of burning pain, warmth, redness, and edema in both toes, feet, legs and calves. Despite extensive medical testing, including genetic analysis, no specific cause was identified.
Renato Ádler Pomilio de Sousa +2 more
doaj +2 more sources
Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy [PDF]
Neurology, 2021 Margot Geerts +6 more
openalex +2 more sources
Sentiment analysis of subcutaneous and intravenous immunoglobulin therapy: public healthcare perception through social media discourse [PDF]
Frontiers in ImmunologyPurposeImmunoglobulin replacement therapy remains a cornerstone of treatment in antibody deficiencies and other inborn errors of immunity. While patient preferences between subcutaneous and intravenous immunoglobulin have been studied through ...
Alejandro Tarango-García +9 more
doaj +2 more sources
Intravenous immunoglobulin therapy for COVID-19 ARDS [PDF]
The Lancet Respiratory Medicine, 2022 Wilfong, Erin M, Matthay, Michael A
openaire +3 more sources
Treatment related fluctuation and response to intravenous immunoglobulin therapy in post COVID-19 Guillain-Barre syndrome [PDF]
Diabetes Metab Syndr, 2021 Subhadeep Gupta +3 more
openalex +3 more sources
Novel Intravenous Immunoglobulin Therapy for the Prevention and Treatment of Candida auris and Candida albicans Disseminated Candidiasis [PDF]
mSphere, 2023 Hong Xin +2 more
openalex +2 more sources
Annals of Pediatric Cardiology, 2021 Background: Standard first-step therapy for Kawasaki disease consists of Intravenous immunoglobulin and high dose Aspirin (80-100 mg/kg/day). The standard dose of Intravenous immunoglobulin (2gr/kg) is strongly effective in reducing the risk of coronary ...
Farima Sanati +3 more
doaj +1 more source
Treatment with intravenous immunoglobulin in a subclinical neonatal myocarditis – Review of the literature and a case report [PDF]
Romanian Journal of Medical Practice, 2023 Myocarditis is an inflammatory disease of the myocardium that is associated with significant morbidity and mortality. We present the case of a male infant born at 38 weeks gestational age detected with subclinical myocarditis. The diagnosis was suggested
Maria-Andreea Racean +3 more
doaj +1 more source
Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement [PDF]
, 2014 Secondary antibody deficiency can occur as a result of haematological malignancies or certain medications, but not much is known about the clinical and immunological features of this group of patients as a whole. Here we describe a cohort of 167 patients
AA Bousfiha +55 more
core +6 more sources